A Tumor-specific Stem Cell
Authors
Affiliations
Suppressing STAT5 signaling affects osteosarcoma growth and stemness.
Subramaniam D, Angulo P, Ponnurangam S, Dandawate P, Ramamoorthy P, Srinivasan P Cell Death Dis. 2020; 11(2):149.
PMID: 32094348 PMC: 7039889. DOI: 10.1038/s41419-020-2335-1.
A novel double-targeted nondrug delivery system for targeting cancer stem cells.
Qiao S, Zhao Y, Geng S, Li Y, Hou X, Liu Y Int J Nanomedicine. 2016; 11:6667-6678.
PMID: 27994463 PMC: 5154727. DOI: 10.2147/IJN.S116230.
Quinomycin A targets Notch signaling pathway in pancreatic cancer stem cells.
Ponnurangam S, Dandawate P, Dhar A, Tawfik O, Parab R, Mishra P Oncotarget. 2015; 7(3):3217-32.
PMID: 26673007 PMC: 4823101. DOI: 10.18632/oncotarget.6560.
DNA methyltransferases: a novel target for prevention and therapy.
Subramaniam D, Thombre R, Dhar A, Anant S Front Oncol. 2014; 4:80.
PMID: 24822169 PMC: 4013461. DOI: 10.3389/fonc.2014.00080.
Vedeld H, Skotheim R, Lothe R, Lind G Epigenetics. 2014; 9(3):346-50.
PMID: 24384857 PMC: 4053453. DOI: 10.4161/epi.27582.